Characteristics

Number

Percent

Characteristics

Number

Percent

Age (years)

T

Mean ± SD

50.23 ± 11.99

T1

8

16%

Median Range

50 (35 - 75)

T2

10

20%

≤55 years

18

36%

T3

22

44%

>55 years

32

64%

T4

10

20%

Pathological type

Lymph node

IDC

39

78%

Negative

18

36%

Other

11

22%

Positive

32

64%

Grade

N

Grade I

7

14%

N0

18

36%

Grade II

13

26%

N1

6

12%

Grade III

30

60%

N2

16

32%

N3

10

20%

ER

M

Negative

20

40%

M0

40

80%

Positive

30

60%

M1

10

20%

PR

AJCC Stage group

Negative

22

45%

Stage I

8

16%

Positive

28

55%

Stage II

10

20%

HER2/neu

Stage III

22

44%

Negative

30

40%

Stage IV

10

20%

Positive

20

60%

Ki-67

FOXC2

low

20

40%

Low

20

40%

high

30

60%

High

30

60%

Molecular type

YKL-40

Luminal A

10

20%

Low

23

46%

Luminal B

10

20%

High

27

54%

HER2 amplified

20

40%

Triple -ve

10

20%

Follow-up (months)

Mean ± SD

28.31 ± 7.27

Median (Range)

30 (15 - 36)

Outcome

Disease free

30/34

84.1%

Local recurrence (LR)

7/34

15.9%

Died

13/50

38.3%